Cargando…
Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression
Lung cancer continues to be the leading cause of cancer-related deaths worldwide due to its high incidence, malignant behaviour and lack of major advancements in treatment strategy. The occurrence and development of lung cancer is closely related to inflammation. Thus, we conducted the present study...
Autores principales: | Wang, Feng, Zhang, Weihua, Wu, Tianfeng, Chu, Heying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223208/ https://www.ncbi.nlm.nih.gov/pubmed/30381361 http://dx.doi.org/10.1098/rsob.180132 |
Ejemplares similares
-
Retraction ‘Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression’
por: Wang, Feng, et al.
Publicado: (2020) -
Expression of concern: Reduced interleukin-38 in non-small cell lung cancer
is associated with tumour progression
por: Wang, Feng, et al.
Publicado: (2020) -
Interleukin-10-regulated tumour tolerance in non-small cell lung cancer
por: Vahl, Julius Malte, et al.
Publicado: (2017) -
Association between interleukin-36γ and tumor progression in non-small cell lung cancer
por: Liu, Lin, et al.
Publicado: (2020) -
Reduced miR-125a-5p level in non-small-cell lung cancer is associated with tumour progression
por: Liu, Hongxu, et al.
Publicado: (2018)